New York, US – Dec 16, 2019 – Unlike other nations across the globe, India is the only country, which is officially termed as the ‘medical travel world’. The people can now obtain medicines exclusively for hepatitis C at a reasonable price. It is currently one of the sought after medical tourist destination spots around the world.
The World Health Organization (WHO) disclosed the fact that approximately one-hundred and fifty million people residing in each country are suffering from severe hepatitis C. It is estimated that nearly seven lakh people succumb to death followed by chronic liver ailments.
In the majority of the cases, people affected with hepatitis-C succeed in curing the ailment. On the other hand, effective treatments are incorporated to cure the people suffering from chronic diseases.
Today Sofosbuvir 400mg/ Velpatasvir 100mg (Epclusa) and ledipasvir 90mg/Sofosbuvir 400mg (Harvoni) are some of the top suggested drugs in treating hepatitis C. In the majority of the countries across the globe; the medicine mentioned above is supplied at an exorbitant rate. Take for example, in the EU; the estimated treatment cost is about eighty-four thousand dollars. It is also not possible for the insurance companies to pay the expenses unless the patient is found to be affected by chronic ailments.
During April, most of the drug manufacturing companies in India had received patent to produce standard versions of Sofosbuvir 400mg/ Velpatasvir 100mg and ledipasvir 90mg/Sofosbuvir 400mg. These drugs are widely available in some of the metropolitan cities in India like New Delhi, Hyderabad and Chennai. The total cost to treat hepatitis C is about one thousand dollars, which means approximately seventy thousand rupees in Indian money.
Owing to the availability of the medicines such as Epclusa and Harvoni, mass influxes of people hailing from Afghanistan, Bangladesh, Yemen, Cambodia, Iraq and Pakistan throng India. Dr. D.Singh, CEO of BonHoa Health – one of the biggest online pharmacy stated that ‘We care India and also care the patients affected with hepatitis C from overseas‘. Dr Nikhil Bondare, an eminent gastroenterologist from Narayana Health City, stated that ‘he is treating about two patients affected with hepatitis C from overseas on a regular basis.’
India now a perfect medical tourist destination spot owing to the abundant supply of this least expensive hepatitis C drugs, the majority of cities in India would capture the attention of countries located around the world.